Founded in Hong Kong in 1994, it is an enterprise integrating the production and sales of pharmaceutical intermediates, pharmaceutical preparations, pharmaceutical packaging materials, etc., and its antibiotics and capsule series products are well-known in the industry
Founded in Hong Kong in 1990, Federated Pharmaceuticals was successfully listed in Hong Kong in June 2007 (stock code: 03933.HK). HK)。 After more than 20 years of development, Federated Pharmaceutical currently has six production entities: Federated Pharmaceutical Factory Co., Ltd. (Hong Kong), Zhuhai Federal Pharmaceutical Co., Ltd., Zhongshan Branch of Zhuhai Federal Pharmaceutical Co., Ltd., Guangdong Kaiping Jinyi Capsule Co., Ltd., Federal Pharmaceutical (Inner Mongolia) Co., Ltd., and Inner Mongolia Federal Animal Protection Pharmaceutical Co., Ltd., with advanced chemical and biological products R&D center and perfect API and preparation marketing team, with a total of about 12,000 employees. R&D, production and operation of APIs and pharmaceutical preparations as one of the comprehensive pharmaceutical group companies.
All the workshops of Federal Pharmaceutical have passed the new GMP certification of China, a number of products have successively obtained German GMP and EU COS certification, and the sterile powder injection products have passed the US FDA certification.
At present, there are 11 series of preparation products, more than 60 varieties and more than 120 specifications, and 5 series of raw material products with nearly 50 varieties. Among them, Amosin Capsule, Ambisen Capsule, Amosin Granules, Crean Oral Liquid, and Neotelloqi Oral Liquid are known as the "three immortals and two waters" in the industry; The recombinant human insulin "Yasling USLIN"® series products have the advantages of high purity, good safety and stable quality; Insulin glargine - "Ulnarin USLEN"® series products use advanced purification technology and production equipment, and the product quality fully meets the standards of the United States Pharmacopoeia. At the same time, Federated Pharmaceutical is also the first enterprise in China to obtain the approval for the production of memantine hydrochloride series products.
Since 1998, Federated Pharmaceutical has completed more than 30 external donation projects in the fields of education, disaster assistance, and social welfare, with a donation amount of nearly 100 million yuan, and has organized employees to participate in public welfare activities such as blood donation, social volunteering, and social charity for many times, reflecting the responsibility and mission of a modern enterprise.
Federated Pharmaceutical, as always, adheres to the commitment of "making life more valuable", is committed to promoting the development of China's medical and health industry, and providing more high-quality and efficient pharmaceutical products for the society.
